Oral treatment of psoriasis with etretinate. 1984

T Yemane-Berhan

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D005050 Etretinate An oral retinoid used in the treatment of keratotic genodermatosis, lichen planus, and psoriasis. Beneficial effects have also been claimed in the prophylaxis of epithelial neoplasia. The compound may be teratogenic. B10-9359,Ethyl Etrinoate,Ro 10-9359,Ro-10-9359,Tigason,Tigazon,B10 9359,B109359,Etrinoate, Ethyl,Ro 10 9359,Ro 109359,Ro109359
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T Yemane-Berhan
September 1986, Therapeutische Umschau. Revue therapeutique,
T Yemane-Berhan
January 1984, Revista medica de Chile,
T Yemane-Berhan
November 1987, Journal of the American Academy of Dermatology,
T Yemane-Berhan
July 1987, Archives of dermatology,
T Yemane-Berhan
January 1987, The Medical letter on drugs and therapeutics,
T Yemane-Berhan
June 1984, Journal of the American Academy of Dermatology,
T Yemane-Berhan
December 1984, Archives of dermatology,
T Yemane-Berhan
January 1988, Dermatologische Monatschrift,
Copied contents to your clipboard!